drugset / Trial / NCT05829655
Measuring Acute Drug Demand in Humans
Phase 0
Recruiting
75 enrolled
University of Maryland, Baltimore
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupTriple-blindBasic science
Summary
This research is being done to evaluate whether suvorexant may reduce the use of, subjective liking, and demand for various drugs.
Timeline
- Start
- 2023-08-08
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Suvorexant | Small molecule | 20 mg | Oral |